Literature DB >> 28271378

Vertical Gastric Bypass with Fundectomy: Feasibility and 2-Year Follow-Up in a Series of Morbidly Obese Patients.

Marco Antonio Zappa1, Alberto Aiolfi2, Cinzia Musolino2, Maria Paola Giusti2, Giovanni Lesti3, Andrea Porta2.   

Abstract

BACKGROUND: Roux-en-Y gastric bypass (RYGB) is the gold standard procedure for morbid obesity and its results are well known and largely discussed. The major limitation of the procedure is the difficult exploration of the excluded gastric pouch and duodenum. The vertical gastric bypass with fundectomy was recently introduced in attempt to overcome these limitations. To date, its effectiveness is debated and outcomes still unclear. The purposes of this study were to describe the vertical gastric bypass with fundectomy and to analyse its outcomes in term of weight loss, complications, and comorbid resolutions.
MATERIAL AND METHODS: Since January 2012 to July 2014, 30 consecutive patients were enrolled and prospectively followed for a 24-month period. All patients underwent the vertical gastric bypass with fundectomy. Follow-up visits were scheduled at 7 days, 1, 6, 12, and 24 months, or whenever necessary.
RESULTS: Overall, 24 women and six men were enrolled in the study. Mean preoperative BMI was 38.2 ± 8.5 kg/m2. No intraoperative complications were reported. Postoperative overall complication rate was 10%. Compliance to the 24-month follow-up was 100%. Mean BMI and excess weight loss (EWL%) were significantly lower compared to baseline (p < 0.05). Comorbid improvement or resolution was recorded in the 80% of the patients.
CONCLUSIONS: Vertical gastric bypass with fundectomy is feasible and effective with similar results in terms of weight loss, complications, and comorbid improving compared to the classic RYGB. Complete evaluation of the gastric anatomy and easy access to the main duodenal papilla are unquestionable advantages.

Entities:  

Keywords:  Bariatric surgery; Gastric fundectomy; Ghrelin; Outcomes; Vertical gastric bypass

Mesh:

Year:  2017        PMID: 28271378     DOI: 10.1007/s11695-017-2620-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  30 in total

Review 1.  Laparoscopic gastric bypass surgery: outcomes.

Authors:  Benjamin E Schneider; Leonardo Villegas; George L Blackburn; Edward C Mun; Jonathan F Critchlow; Daniel B Jones
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2003-08       Impact factor: 1.878

2.  A functional Roux-en-Y gastric bypass to avoid gastric exclusion: 1-year results.

Authors:  Stefano Cariani; Giovanni Vittimberga; Sergio Grani; Andrea Lucchi; Manuela Guerra; Enrico Amenta
Journal:  Obes Surg       Date:  2003-10       Impact factor: 4.129

Review 3.  Linear stapler technique may be safer than circular in gastrojejunal anastomosis for laparoscopic Roux-en-Y gastric bypass: a meta-analysis of comparative studies.

Authors:  Salvatore Giordano; Paulina Salminen; Fausto Biancari; Mikael Victorzon
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

4.  Laparoscopy-assisted transgastric endoscopic retrograde cholangiopancreatography (ERCP) after Roux-en-Y gastric bypass: technical features.

Authors:  Enrico Facchiano; Giovanni Quartararo; Vittorio Pavoni; Gadiel Liscia; Riccardo Naspetti; Alessandro Sturiale; Marcello Lucchese
Journal:  Obes Surg       Date:  2015-02       Impact factor: 4.129

5.  Use of double-balloon enteroscopy to perform PEG in the excluded stomach after Roux-en-Y gastric bypass.

Authors:  Andrew S Ross; Carol Semrad; John Alverdy; Irving Waxman; Charles Dye
Journal:  Gastrointest Endosc       Date:  2006-11       Impact factor: 9.427

Review 6.  Gastric cancer following bariatric surgery: a review.

Authors:  Giulio Orlando; Vincenzo Pilone; Antonio Vitiello; Rita Gervasi; Maria A Lerose; Gianfranco Silecchia; Alessandro Puzziello
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2014-10       Impact factor: 1.719

7.  Management of acute bleeding after laparoscopic Roux-en-Y gastric bypass.

Authors:  Amir Mehran; Samuel Szomstein; Nathan Zundel; Raul Rosenthal
Journal:  Obes Surg       Date:  2003-12       Impact factor: 4.129

8.  Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity.

Authors:  M L Shiffman; H J Sugerman; J M Kellum; W H Brewer; E W Moore
Journal:  Am J Gastroenterol       Date:  1991-08       Impact factor: 10.864

9.  Late gastrointestinal hemorrhage after gastric bypass.

Authors:  Scott C Braley; Ninh T Nguyen; Bruce M Wolfe
Journal:  Obes Surg       Date:  2002-06       Impact factor: 4.129

10.  Failure of gastric bypass following several gastrointestinal hemorrhages.

Authors:  Enrico Mozzi; Ezio Lattuada; Marco Antonio Zappa; Ilaria Antonini; Francesco Andreoli; Sara Badiali; Giancarlo Roviaro
Journal:  Obes Surg       Date:  2008-07-19       Impact factor: 4.129

View more
  4 in total

1.  Laparoscopic Gastric Bypass with Fundectomy and Gastric Remnant Exploration (LRYGBfse): Results at 5-Year Follow-up.

Authors:  Giovanni Lesti; Alberto Aiolfi; Enrico Mozzi; Fabrizio Altorio; Ezio Lattuada; Francesco Lesti; Gianluca Bonitta; Marco Antonio Zappa
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

2.  Remnant Gastric Cancer After Roux-en-Y Gastric Bypass: Narrative Review of the Literature.

Authors:  Stefania Tornese; Alberto Aiolfi; Gianluca Bonitta; Emanuele Rausa; Guglielmo Guerrazzi; Piero Giovanni Bruni; Giancarlo Micheletto; Davide Bona
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

3.  Resectional One Anastomosis Gastric Bypass/Mini Gastric Bypass as a Novel Option for Revision of Restrictive Procedures: Preliminary Results.

Authors:  Roger Noun; Rita Slim; Ghassan Chakhtoura; Joseph Gharios; Elie Chouillard; Carla Tohmé-Noun
Journal:  J Obes       Date:  2018-09-18

4.  Gastric cancer after gastric bypass with fundectomy: The possibility for early diagnosis.

Authors:  Marco Antonio Zappa; Maria Paola Giusti; Elisa Galfrascoli
Journal:  Int J Surg Case Rep       Date:  2019-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.